SCH 900518
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SCH 900518, covering 2015-01-22 to 2015-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695) [Phase 1]